KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Current Assets (2016 - 2025)

Resmed (RMD) has disclosed Current Assets for 16 consecutive years, with $3.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 34.65% year-over-year to $3.8 billion, compared with a TTM value of $4.6 billion through Dec 2025, up 47.95%, and an annual FY2025 reading of $3.5 billion, up 48.69% over the prior year.
  • Current Assets was $3.8 billion for Q4 2025 at Resmed, up from $3.6 billion in the prior quarter.
  • Across five years, Current Assets topped out at $3.8 billion in Q4 2025 and bottomed at -$4.5 billion in Q1 2024.
  • Average Current Assets over 5 years is $2.1 billion, with a median of $2.3 billion recorded in 2022.
  • The sharpest move saw Current Assets tumbled 290.92% in 2024, then skyrocketed 171.89% in 2025.
  • Year by year, Current Assets stood at $1.5 billion in 2021, then skyrocketed by 50.28% to $2.3 billion in 2022, then rose by 2.28% to $2.4 billion in 2023, then increased by 19.26% to $2.8 billion in 2024, then skyrocketed by 34.65% to $3.8 billion in 2025.
  • Business Quant data shows Current Assets for RMD at $3.8 billion in Q4 2025, $3.6 billion in Q3 2025, and $3.5 billion in Q2 2025.